Adult-specific functions of animal microRNAs

Nature Reviews Genetics

Volumn 14, Issue 8, 2013, Pages 535-548

  Sun, Kailiang ^a   Lai, Eric C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 124; MICRORNA 132; MICRORNA 223; MYOGENIC FACTOR 5; SMAD PROTEIN; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA;

ADULT STEM CELL; AGING; APOPTOSIS; ASTROCYTE; ATAXIA; B CELL LYMPHOMA; CELL DIFFERENTIATION; CELL LINEAGE; CEREBELLUM DEGENERATION; CHRONIC LYMPHATIC LEUKEMIA; CIRCADIAN RHYTHM; DNA METHYLATION; DOPAMINERGIC NERVE CELL; DROSOPHILA MELANOGASTER; GENE FUNCTION; GLUCOSE HOMEOSTASIS; HEMATOPOIETIC STEM CELL; HUMAN; LEARNING; LIPID METABOLISM; LYMPHOCYTE DIFFERENTIATION; LYMPHOPROLIFERATIVE DISEASE; MEMORY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PURKINJE CELL; REVIEW; SATELLITE CELL; SKELETAL MUSCLE; SKIN;

AGE FACTORS; ANIMALS; HUMANS; MICRORNAS;

ANIMALIA;

EID: 84880921276     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg3471     Document Type: Review

References (193)

1. Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906 (2000). (Pubitemid 30130993)
2. Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (1993). (Pubitemid 24014542)
3. Lai, E. C., Burks, C. & Posakony, J. W. The K box, a conserved 3' UTR sequence motif, negatively regulates accumulation of Enhancer of split complex transcripts. Development 125, 4077-4088 (1998). (Pubitemid 28515445)
4. Lai, E. C. & Posakony, J. W. The Bearded box, a novel 3' UTR sequence motif, mediates negative post-transcriptional regulation of Bearded and Enhancer of split complex gene expression. Development 124, 4847-4856 (1997). (Pubitemid 28014387)
5. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853-858 (2001). (Pubitemid 33032103)
6. Lau, N., Lim, L., Weinstein, E. & Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862 (2001). (Pubitemid 33032104)
7. Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862-864 (2001). (Pubitemid 33032105)
8. Lai, E. C. microRNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genet. 30, 363-364 (2002).
9. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787-798 (2003). (Pubitemid 38058492)
10. Krek, A. et al. Combinatorial microRNA target predictions. Nature Genet. 37, 495-500 (2005). (Pubitemid 40617277)
11. Flynt, A. S. & Lai, E. C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nature Rev. Genet. 9, 831-842 (2008).
12. Yang, J. S. & Lai, E. C. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol. Cell 43, 892-903 (2011).
13. Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nature Struct. Mol. Biol. 19, 586-593 (2012).
14. Kasinski, A. L. & Slack, F. J. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nature Rev. Cancer 11, 849-864 (2011).
15. Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336-342 (2011).
16. Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187 (2012).
17. Dai, Q., Smibert, P. & Lai, E. C. Exploiting Drosophila genetics to understand microRNA function and regulation. Curr. Top. Dev. Biol. 99, 201-235 (2012).
18. Miska, E. A. et al. Most Caenorhabditis elegans microRNAs are individually not essential for development or viability. PLoS Genet. 3, e215 (2007).
19. Alvarez-Saavedra, E. & Horvitz, H. R. Many families of C. elegans microRNAs are not essential for development or viability. Curr. Biol. 20, 367-373 (2010). These papers describe nematode mutants for most individual miRNAs and miRNA families, most of which lack overt developmental or behavioural phenotypes and are viable and fertile.
20. Huang, T. C. et al. Regulation of lipid metabolism by Dicer revealed through SILAC mice. J. Proteome Res. 11, 2193-2205 (2012).
21. Hatfield, S. D. et al. Stem cell division is regulated by the microRNA pathway. Nature 435, 974-978 (2005). (Pubitemid 40896325)
22. Jin, Z. & Xie, T. Dcr-1 maintains Drosophila ovarian stem cells. Curr. Biol. 17, 539-544 (2007). (Pubitemid 46401374)
23. Yang, L. et al. Argonaute 1 regulates the fate of germline stem cells in Drosophila. Development 134, 4265-4272 (2007).
24. Park, J. K., Liu, X., Strauss, T. J., McKearin, D. M. & Liu, Q. The miRNA pathway intrinsically controls self-renewal of Drosophila germline stem cells. Curr. Biol. 17, 533-538 (2007). (Pubitemid 46401377)
25. Forstemann, K. et al. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol. 3, e236 (2005).
26. Yang, Y. et al. The bantam microRNA is associated with Drosophila fragile X mental retardation protein and regulates the fate of germline stem cells. PLoS Genet. 5, e1000444 (2009).
27. Azzam, G., Smibert, P., Lai, E. C. & Liu, J. L. Drosophila Argonaute 1 and its miRNA biogenesis partners are required for oocyte formation and germline cell division. Dev. Biol. 365, 384-394 (2012).
28. Greenlee, A. R. et al. Deregulated sex chromosome gene expression with male germ cell-specific loss of dicer1. PLoS ONE 7, e46359 (2012).
29. Ming, G. L. & Song, H. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70, 687-702 (2011).
30. Cheng, L. C. Pastrana, E., Tavazoie, M. & Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nature Neurosci. 12, 399-408 (2009).
31. Scott, C. E. et al. SOX9 induces and maintains neural stem cells. Nature Neurosci. 13, 1181-1189 (2010).
32. Akerblom, M. et al. MicroRNA-124 is a subventricular zone neuronal fate determinant. J. Neurosci. 32, 8879-8889 (2012).
33. Yoo, A. S. et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 476, 228-231 (2011).
34. de Chevigny, A. et al. miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons. Nature Neurosci. 15, 1120-1126 (2012).
35. Liu, C. et al. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 6, 433-444 (2010).
36. Szulwach, K. E. et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J. Cell Biol. 189, 127-141 (2010).
37. Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86 (2004). (Pubitemid 38055775)
38. Petriv, O. I. et al. Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc. Natl Acad. Sci. USA 107, 15443-15448 (2010).
39. Guo, S. et al. MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl Acad. Sci. USA 107, 14229-14234 (2010).
40. O'Connell, R. M. & Baltimore, D. MicroRNAs and hematopoietic cell development. Curr. Top. Dev. Biol. 99, 145-174 (2012).
41. Ventura, A. et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886 (2008). (Pubitemid 351312807)
42. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008). (Pubitemid 351317447)
43. Xiao, C. et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159 (2007). (Pubitemid 47498525)
44. Rasmussen, K. D. et al. The miR-144/451 locus is required for erythroid homeostasis. J. Exp. Med. 207, 1351-1358 (2010).
45. Yu, D. et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3ζ. Genes Dev. 24, 1620-1633 (2010).
46. Patrick, D. M. et al. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3ζ. Genes Dev. 24, 1614-1619 (2010).
47. Lu, J. et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev. Cell 14, 843-853 (2008). (Pubitemid 351757199)
48. Pannerec, A., Marazzi, G. & Sassoon, D. Stem cells in the hood: the skeletal muscle niche. Trends Mol. Med. 18, 599-606 (2012).
49. Crist, C. G. et al. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc. Natl Acad. Sci. USA 106, 13383-13387 (2009).
50. Chen, J. F. et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol. 190, 867-879 (2010).
51. Liu, N. et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J. Clin. Invest. 122, 2054-2065 (2012).
52. Dey, B. K., Gagan, J., Yan, Z. & Dutta, A. miR-26a is required for skeletal muscle differentiation and regeneration in mice. Genes Dev. 26, 2180-2191 (2012).
53. Abou-Khalil, R. & Brack, A. S. Muscle stem cells and reversible quiescence: the role of sprouty. Cell Cycle 9, 2575-2580 (2010).
54. Cheung, T. H. et al. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 482, 524-528 (2012).
55. Crist, C. G., Montarras, D. & Buckingham, M. Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell 11, 118-126 (2012).
56. Yi, R., Poy, M. N., Stoffel, M. & Fuchs, E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452, 225-229 (2008). (Pubitemid 351380241)
57. Teta, M. et al. Inducible deletion of epidermal Dicer and Drosha reveals multiple functions for miRNAs in postnatal skin. Development 139, 1405-1416 (2012).
58. Wang, W., Kwon, E. J. & Tsai, L. H. MicroRNAs in learning, memory, and neurological diseases. Learn. Mem. 19, 359-368 (2012).
59. Krol, J. et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141, 618-631 (2010). This paper describes the rapid turnover of miRNAs modulated by neuronal activities.
60. McNeill, E. & Van Vactor, D. MicroRNAs shape the neuronal landscape. Neuron 75, 363-379 (2012).
61. De Pietri Tonelli, D. et al. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 135, 3911-3921 (2008).
62. Davis, T. H. et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28, 4322-4330 (2008).
63. Schaefer, A. et al. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 204, 1553-1558 (2007). (Pubitemid 47048023)
64. Tao, J. et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306-8319 (2011).
65. Konopka, W. et al. MicroRNA loss enhances learning and memory in mice. J. Neurosci. 30, 14835-14842 (2010). This paper demonstrated that loss of miRNAs is initially beneficial to cognitive tasks before the onset of neurodegeneration.
66. Gao, J. et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109 (2010).
67. Jimenez-Mateos, E. M. et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nature Med. 18, 1087-1094 (2012).
68. Wanet, A., Tacheny, A., Arnould, T. & Renard, P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res. 40, 4742-4753 (2012).
69. Yang, Y. et al. EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73, 774-788 (2012).
70. Kadener, S. et al. A role for microRNAs in the Drosophila circadian clock. Genes Dev. 23, 2179-2191 (2009).
71. Luo, W. & Sehgal, A. Regulation of circadian behavioral output via a microRNA-JAK/STAT circuit. Cell 148, 765-779 (2012).
72. Zhang, Y. & Emery, P. GW182 controls Drosophila circadian behavior and PDF-receptor signaling. Neuron 78, 152-165 (2013).
73. Cheng, H. Y. et al. microRNA modulation of circadian-clock period and entrainment. Neuron 54, 813-829 (2007).
74. Alvarez-Saavedra, M. et al. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum. Mol. Genet. 20, 731-751 (2011).
75. Pietrzykowski, A. Z. et al. Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59, 274-287 (2008). (Pubitemid 352033687)
76. Hollander, J. A. et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 466, 197-202 (2010).
77. Lippi, G. et al. Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J. Cell Biol. 194, 889-904 (2011).
78. da Costa Martins, P. A. et al. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 118, 1567-1576 (2008).
79. Albinsson, S. et al. Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function. PLoS ONE 6, e18869 (2011).
80. Abdellatif, M. Differential expression of microRNAs in different disease states. Circ. Res. 110, 638-650 (2012).
81. van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579 (2007). (Pubitemid 46683138)
82. van Rooij, E. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17, 662-673 (2009).
83. van Rooij, E. & Olson, E. N. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature Rev. Drug Discov. 11, 860-872 (2012).
84. Bernardo, B. C. et al. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc. Natl Acad. Sci. USA 109, 17615-17620 (2012).
85. da Costa Martins, P. A. et al. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling. Nature Cell Biol. 12, 1220-1227 (2010).
86. Lin, Z. et al. miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl Acad. Sci. USA 106, 12103-12108 (2009).
87. Ucar, A. et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nature Commun. 3, 1078 (2012).
88. Aurora, A. B. et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death. J. Clin. Invest. 122, 1222-1232 (2012).
89. Rottiers, V. & Naar, A. M. MicroRNAs in metabolism and metabolic disorders. Nature Rev. Mol. Cell Biol. 13, 239-250 (2012).
90. Horie, T. et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (SREBP2) regulates HDL in vivo. Proc. Natl Acad. Sci. USA 107, 17321-17326 (2010).
91. Marquart, T. J., Allen, R.M., Ory, D.S. & Baldan, A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl Acad. Sci. USA 107, 12228-12232 (2010).
92. Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569 (2010).
93. Rayner, K. J. et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
94. Rayner, K. J. et al. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121, 2921-2931 (2011).
95. Rayner, K. J. et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478, 404-407 (2011). This paper demonstrateas the benefit of pharmacological inhibition of miR-33 in non-human primates.
96. Davalos, A. et al. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc. Natl Acad. Sci. USA 108, 9232-9237 (2011).
97. Poy, M. N. et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230 (2004). (Pubitemid 39545853)
98. Poy, M. N. et al. miR-375 maintains normal pancreatic α- and β-cell mass. Proc. Natl Acad. Sci. USA 106, 5813-5818 (2009).
99. Kornfeld, J. W. et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 494, 111-115 (2013).
100. Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649-653 (2011).
101. Jordan, S. D. et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nature Cell Biol. 13, 434-446 (2011).
102. Frost, R. J. & Olson, E. N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl Acad. Sci. USA 108, 21075-21080 (2011).
103. Zhu, H. et al. The Lin28/let-7 axis regulates glucose metabolism. Cell 147, 81-94 (2011).
104. Grueter, C. E. et al. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149, 671-683 (2012).
105. Smith-Vikos, T. & Slack, F. J. MicroRNAs and their roles in aging. J. Cell Sci. 125, 7-17 (2012).
106. Boehm, M. & Slack, F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 310, 1954-1957 (2005). (Pubitemid 43005988)
107. Lehrbach, N. J. et al. Post-developmental microRNA expression is required for normal physiology, and regulates aging in parallel to insulin/IGF-1 signaling in C. elegans. RNA 18, 2220-2235 (2012). This paper shows how a temperature-sensitive mutant of a core miRNA biogenesis factor could be used to assess miRNA functions in post-developmental settings in a reversible manner.
108. Boulias, K. & Horvitz, H. R. The C. elegans microRNA mir-71 acts in neurons to promote germline-mediated longevity through regulation of DAF-16/FOXO. Cell. Metab. 15, 439-450 (2012).
109. de Lencastre, A. et al. MicroRNAs both promote and antagonize longevity in C. elegans. Curr. Biol. 20, 2159-2168 (2010).
110. Yang, J. et al. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age 35, 11-22 (2013).
111. Pincus, Z., Smith-Vikos, T. & Slack, F. J. MicroRNA predictors of longevity in Caenorhabditis elegans. PLoS Genet. 7, e1002306 (2011).
112. Ugalde, A. P. et al. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J. 30, 2219-2232 (2011).
113. Nishino, J., Kim, I., Chada, K. & Morrison, S. J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression. Cell 135, 227-239 (2008).
114. Li, G. et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nature Med. 18, 1518-1524 (2012).
115. Toledano, H., D'Alterio, C., Czech, B., Levine, E. & Jones, D. L. The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche. Nature 485, 605-610 (2012).
116. Zou, Y. et al. Developmental decline in neuronal regeneration by the progressive change of two intrinsic timers. Science 340, 372-376 (2013).
117. Shen, Y., Wollam, J., Magner, D., Karalay, O. & Antebi, A. A steroid receptor-microRNA switch regulates life span in response to signals from the gonad. Science 338, 1472-1476 (2012).
118. Liu, N. et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523 (2012).
119. Boon, R. A. et al. MicroRNA-34a regulates cardiac ageing and function. Nature 495, 107-110 (2013).
120. Minones-Moyano, E. et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078 (2011).
121. Zovoilis, A. et al. microRNA-34c is a novel target to treat dementias. EMBO J. 30, 4299-4308 (2011).
122. Lujambio, A. & Lowe, S. W. The microcosmos of cancer. Nature 482, 347-355 (2012).
123. Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (2005). (Pubitemid 40343076)
124. Mayr, C., Hemann, M. T. & Bartel, D. P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579 (2007). (Pubitemid 46449474)
125. He, L. et al. A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (2007). (Pubitemid 47014436)
126. Raver-Shapira, N. et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743 (2007). (Pubitemid 46856247)
127. Chang, T. C. et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
128. Pramanik, D. et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 10, 1470-1480 (2011).
129. Esquela-Kerscher, A. et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7, 759-764 (2008). (Pubitemid 351520040)
130. Liu, C. et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nature Med. 17, 211-215 (2011).
131. Kumar, M. S. et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl Acad. Sci. USA 105, 3903-3908 (2008). (Pubitemid 351723497)
132. Choi, Y. J. et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nature Cell Biol. 13, 1353-1360 (2011).
133. Concepcion, C. P. et al. Intact p53-dependent responses in miR-34-deficient mice. PLoS Genet. 8, e1002797 (2012). In contrast to the expected tumour suppressive function of miR-34, this study showed that mice carrying mutations in all three mir-34 genes did not exhibit increased susceptibility to cancer.
134. Calin, G. A. et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 99, 15524-15529 (2002). (Pubitemid 35403967)
135. Klein, U. et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17, 28-40 (2010).
136. Tsai, W. C. et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122, 2884-2897 (2012).
137. Hsu, S. H. et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J. Clin. Invest. 122, 2871-2883 (2012).
138. Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005-1017 (2009). This paper demonstrates the selective action of miR-26 in cancer cells in a liver cancer model.
139. Huse, J. T. et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23, 1327-1337 (2009).
140. Mavrakis, K. J. et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nature Genet. 43, 673-678 (2011).
141. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 22, 894-907 (2008). (Pubitemid 351482843)
142. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biol. 10, 593-601 (2008). (Pubitemid 351627379)
143. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
144. Ma, L. et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotech. 28, 341-347 (2010).
145. Valastyan, S., Chang, A., Benaich, N., Reinhardt, F. & Weinberg, R. A. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 25, 646-659 (2011).
146. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008).
147. Martello, G. et al. A MicroRNA targeting dicer for metastasis control. Cell 141, 1195-1207 (2010).
148. Zhang, J. & Ma, L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev. 31, 653-662 (2012).
149. Ota, A. et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087-3095 (2004). (Pubitemid 38581408)
150. He, L. et al. A microRNA polycistron as a potential human oncogene. Nature 435, 828-833 (2005). (Pubitemid 40839734)
151. Mu, P. et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23, 2806-2811 (2009).
152. Olive, V. et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23, 2839-2849 (2009).
153. Mavrakis, K. J. et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature Cell Biol. 12, 372-379 (2010).
154. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257-2261 (2006). (Pubitemid 43271657)
155. Hatley, M. E. et al. Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282-293 (2010).
156. Ma, X. et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc. Natl Acad. Sci. USA 108, 10144-10149 (2011).
157. Medina, P. P., Nolde, M. & Slack, F. J. Oncomir addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90 (2010). This paper presents a proof-of-principle of the idea of oncomir addiction.
158. Rodriguez, A. et al. Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611 (2007). (Pubitemid 46683148)
159. Thai, T. H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604-608 (2007).
160. Costinean, S. et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(μ)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA 103, 7024-7029 (2006).
161. Babar, I. A. et al. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc. Natl Acad. Sci. USA 109, E1695-E1704 (2012).
162. Smibert, P. & Lai, E. C. Lessons from microRNA mutants in worms, flies and mice. Cell Cycle 7, 2500-2508 (2008).
163. Choi, W. Y., Giraldez, A. J. & Schier, A. F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318, 271-274 (2007). (Pubitemid 47574854)
164. Brenner, J. L., Jasiewicz, K. L., Fahley, A. F., Kemp, B. J. & Abbott, A. L. Loss of individual microRNAs causes mutant phenotypes in sensitized genetic backgrounds in C. elegans. Curr. Biol. 20, 1321-1325 (2010).
165. Bejarano, F. et al. A genome-wide transgenic resource for conditional expression of Drosophila microRNAs. Development 139, 2821-2831 (2012).
166. Szuplewski, S. et al. MicroRNA transgene overexpression complements deficiency-based modifier screens in Drosophila. Genetics 190, 617-626 (2012).
167. Smibert, P. & Lai, E. C. A view from Drosophila: multiple biological functions for individual microRNAs. Semin. Cell Dev. Biol. 21, 745-753 (2010).
168. Park, C. Y. et al. A resource for the conditional ablation of microRNAs in the mouse. Cell Rep. 1, 385-391 (2012).
169. Prosser, H. M., Koike-Yusa, H., Cooper, J. D., Law, F. C. & Bradley, A. A resource of vectors and ES cells for targeted deletion of microRNAs in mice. Nature Biotech. 29, 840-845 (2011).
170. Xu, T. & Rubin, G. M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117, 1223-1237 (1993). (Pubitemid 23154489)
171. Hutvagner, G., Simard, M. J., Mello, C. C. & Zamore, P. D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2, E98 (2004).
172. Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689 (2005).
173. Obad, S. et al. Silencing of microRNA families by seed-targeting tiny LNAs. Nature Genet. 43, 371-378 (2011).
174. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4, 721-726 (2007). (Pubitemid 47338166)
175. Ebert, M. S. & Sharp, P. A. MicroRNA sponges: progress and possibilities. RNA 16, 2043-2050 (2010).
176. Haraguchi, T., Ozaki, Y. & Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43 (2009).
177. Xie, J. et al. Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nature Methods 9, 403-409 (2012).
178. Mullokandov, G. et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nature Methods 9, 840-846 (2012).
179. Kloosterman, W. P., Lagendijk, A. K., Ketting, R. F., Moulton, J. D. & Plasterk, R. H. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 5, e203 (2007).
180. Leaman, D. et al. Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 121, 1097-1108 (2005). (Pubitemid 40884399)
181. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
182. Patrick, D. M. et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120, 3912-3916 (2010). These two studies show how different in vivo results can be obtained using antagomir and genetic knockouts.
183. Cordes, K. R. et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-710 (2009).
184. Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the mir143/145 gene cluster. J. Clin. Invest. 119, 2634-2647 (2009).
185. Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166-2178 (2009).
186. Tarasov, V. et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593 (2007). (Pubitemid 47327945)
187. Welch, C., Chen, Y. & Stallings, R. L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26, 5017-5022 (2007). (Pubitemid 47172643)
188. Jain, A. K. & Barton, M. C. Unmet expectations: miR-34 plays no role in p53-mediated tumor suppression in vivo. PLoS Genet. 8, e1002859 (2012).
189. Esau, C. et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Metab. 3, 87-98 (2006).
190. Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008). (Pubitemid 351550859)
191. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309, 1577-1581 (2005). (Pubitemid 41266486)
192. Lindow, M. & Kauppinen, S. Discovering the first microRNA-targeted drug. J. Cell Biol. 199, 407-412 (2012).
193. Hsu, Y.-C. & Fuchs, E. A family business: stem cell progeny join the niche to regulate homeostasis. Nature Rev. Mol. Cell. Biol. 13, 103 (2012).